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Cancer cachexia is a complex syndrome that affects the 
majority of cancer patients with advanced disease and 
impacts adversely on quality of life, treatment tolerance 
and overall survival [1]. Muscle wasting is a key feature 
of cancer cachexia and low muscularity has been shown 
to impact on the strength, mobility, treatment tolerance 
and  independence  of  the  cancer  patient   [2].  Animal  
 
 












































studies have suggested there may be direct or indirect 
effects of the tumour resulting in muscle atrophy via 
either decreased myofibrillar protein synthesis, 
increased protein degradation or a combination of the 
two [3]. Studies of protein metabolism in cancer in 
humans are both limited and contradictory [4,5] and 
have raised the question whether a different mechanism 
such as failure of myofibre regeneration may be 
important. In adult humans, muscle mass is lost at 
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and CWL: 10), HE: 21 and HMA: 20 underwent biopsy of quadriceps muscle. The expression of  transcription  factors  for
muscle regeneration (Pax3, Pax7 and MyoD) was increased in CWS and HE compared with HMA (p<0.001). In contrast, the
expression  of  the  late  myogenic  differentiation  marker  MyoG  was  reduced  in  CWS  and  CWL  but  increased  in  HE
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~1%/year after the age of 30 years [6]. This process is 
thought to involve a loss of regenerative capacity in the 
muscle. Nearly 50% of cancer patients are over the age 
of 70 years and therefore significant pre-morbid age-
related muscle loss (sarcopenia) is prevalent in any 
general cancer population. Equally, many cancer 
patients have co-morbidities that can result in 
significant muscle wasting e.g. chronic obstructive 
pulmonary disease, chronic renal failure or chronic 
heart failure. Finally, different forms of cancer therapy 
(chemotherapy, radiotherapy, surgery, targeted therapy) 
can also induce muscle wasting [1]. Thus, the origin of 
muscle wasting in any individual cancer patient may be 
both complex and diverse. 
 
In healthy adult muscle, satellite cells remain in a non-
proliferative, quiescent state and are characterized by 
the co-expression of transcription factors Pax7 and 
Pax3. Following proliferation, satellite cells maintain 
the myogenic factors required for myogenic 
determination including Myf5, MyoD and MyoG, while 
Pax7 and Pax3 expression is reduced progressively. 
Activation of muscle specific genes Myf5, MyoD and 
MyoG is dependent on the Mef2 (myocyte enhancer 
factor 2) which lacks myogenic activity alone but 
cooperatively increase the activity of myogenic 
transcription factors. Subsequently, the cells which 
begin terminal differentiation start to express factors 
such as MRF4, myogenin and myosin [7]. Ultimately, 
these cells fuse to existing damaged muscle fibers or fuse 
together to form new myofibers during regeneration of 
damaged skeletal muscle. Loss of skeletal muscle may 
result from an inability of activated myogenic cells to 
differentiate and fuse and thereby restore functional 
fibers due to prematurely impaired myogenesis [8]. 
 
Inflammatory cytokines may contribute to the pathology 
of muscle wasting and defective skeletal muscle 
regeneration [9]. Epidemiological studies of ageing 
indicate that IL-6 may also be involved in age-related 
decline of muscle function [10,11]. In conjunction with 
TNF- α, IL-6 has also been implicated in the 
progression of sarcopenia [12]. While increased 
circulating TNF- α and IL-6 may be markers of 
systemic inflammation, within muscle it is upregulation 
of the transcription factor NF-ĸB that may act as a node 
for inflammatory pathways and promote muscle 
degeneration [13]. Elevated activity of NF-ĸB has been 
suggested to suppress MyoD mRNA, leading to 
dysfunction of skeletal myofibers and muscle loss 
[14,15] although one study did not indicate a role for 
NFkB [16]. Non-specific chronic inflammatory 
processes within the muscle, with excessive production 
of pro-inflammatory cytokines, may in turn increase the 
expression of inducible nitric oxide synthase (iNOS) 
and production of reactive oxygen/nitrogen species 
(ROS) which can promote muscle weakness and 
fatigue. ROS can act via redox signaling mechanisms to 
alter myogenic gene expression, causing protein loss 
that reduces muscle mass [17]. Secondly, high 
intracellular ROS also can act via post-translational 
mechanisms to modify or impair constitutively 
expressed proteins, causing muscle dysfunction [18]. 
These two pathways may be regulated independently 
and can have separate or additive effects on skeletal 
muscle function and regenerative potential. Here, we 
focus on the potential role of oxidative stress and 
apoptosis as a result of inappropriate inflammation in 
the muscle microenvironment and as a result of 
mitochondrial damage or inactivation of antioxidant and 
detoxification systems. The adverse effects of these 
mechanisms may act through stimulation of nuclear 
erythroid-2-p45-related factor-2 (Nrf2) and autophagy 
pathways [19]. 
 
There are clear indications that satellite cells play a role 
in skeletal muscle re-modelling, growth and atrophy [20] 
and that reduced regrowth of muscle and a reduction in 
myogenic precursor activity following a period of 
immobility is associated with aging. It is plausible that 
inflammation-induced oxidative stress may play a role in 
the progression of muscle atrophy which subsequently 
may affect satellite cell activity and muscle fiber 
remodeling. This study aims to investigate not only the 
transcriptional differences in satellite cell activity 
between muscle in healthy aging and patients with cancer 




Patient and volunteer characteristics 
 
The characteristics of the cancer group (C - WS and 
WL), healthy elderly (HE) and healthy middle aged 
control (HMA) groups are presented in Table 1. The 
majority of the cancer patients were male with a mean 
age of 66 years and an average BMI of 26. Ten patients 
had lost >5% of their pre-illness weight (cachexia). 
Most of the cancer patients were Stage II/III disease 
reflecting their work-up for resectional surgery. 
Approximately thirty percent had an elevated C-reactive 
protein. The healthy elderly were more balanced in their 
sex distribution and had a mean age of 79 yrs. The HE 
had a mean BMI of 25.4, all were weight-stable and 
none had an elevated serum C-reactive protein. The 
healthy middle-aged controls were, on average, nearly 
two decades younger than the HE and 5 years younger 
than the cancer patients. There was a predominance of 
males, average BMI was in the normal range (data not 
shown), and all were weight-stable. 
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Expression of satellite cell activation and myogenic 
differentiation 
 
The expression of the muscle transcription factor Pax3 
was significantly higher in both cancer groups and HE 
compared with HMA (Fig. 1a). A similar pattern was 
observed for Pax7 but this was only elevated in CWS and 
















































expression of markers of early myogenesis (MyoD and 
Myf5) in both HE and CWS when compared with HMA 
(Fig. 1b). Myf5 was also increased in CWL compared 
with HMA (Fig. 1b). When compared with HMA there 
was elevated expression of myogenin (MyoG) in the HE 
possibly indicating the ongoing potential for myogenic 
fusion (Fig.1c). In contrast, myogenin was down- 





















































(p<0.0001  in HE and p<0.001  in CWS) and Myf5  (p<0.0001  in HE and CWS, P<0.005  in CWL)  compared with HMA. The expression of
MyoG is upregulated in HE (p<0.0001) compared with HMA and reduced in CWS and CWL (p<0.0001) compared with HMA. 
  


























































 Cancer (n=28) HMA (n=20) HE (n=21) 





M:F 13:5 8:2 12:8 e 11:10 
Age 67 (10.5)  65 (8.1) 61 (7) e 79 (3.6) 
Weight 81.8 (14.1) 81.5 (19.3) 73 (12) e 69 (14) 
Height 1.69 (0.11) 1.73 (0.1) 1.73 (0.10)  e 1.65 (0.09) 
BMI 26.6 (4.0) 26 (3.7)  25.4 (3.8) 
% WL 6.5 (9.3) 9.3 (7.8) - - 
LBM (kg)    48.1 (10.5) 
FM (kg)    19.1 (6.6) 
ASM (kg/m2) 6.4 (0.64) 5.6 (0.4) 7.9 (1.0) e 7.3 (1.3) 
% Cachectic ** 0% 36%   



















CRP (mg/L) 16.3 (24.8) 26.9 (57.3)  3 (2.5) 




years  and  an average BMI  (±SD) of 26 ± 3.7. Most of  the  cancer patients were  Stage  II/III disease  reflecting  their work‐up  for 

















































Expression of pro-inflammatory cytokines and 
NFĸB 
 
When compared with HMA, message for TNF-α was 
highly expressed in the muscle of HE (30 fold) and to a 
lesser extent in the muscle of CWS (3 fold) (Fig. 2a). 
IL-6 message was significantly increased only in CWS 
compared with HMA (Fig. 2a). Samples for Western 
blot analysis were not available for the HMA group and 
for only a subgroup of the cancer patients (n=9). In 
view of the small sample size, CWS and CWL were 
amalgamated into one cancer (C) group. Using Western 
blot analysis, the p-NFĸB/total NFĸB ratio was not 
significantly different between the HE and C groups. 
Similarly, levels of pNF-ĸB and total NF-ĸB protein 
levels were not significantly elevated in the muscle of 







































Expression of apoptotic factors, autophagy and 
oxidative stress defense genes 
 
The expression of the pro-apoptotic gene Bax (Fig. 3a) 
was significantly increased in CWS, CWL and HE 
compared with HMA (P<0.001). In HE, CWS and 
CWL, expression of message for Sequestosome 1 
(p62/SQSTM1), p62, which is an indicator of oxidative 
stress, was significantly different from HMA (Fig. 3a). 
Both Beclin and p62 protein expression were 
significantly increased in cancer compared with HE. 
Expression of message for the oxidative defense genes 
SOD2, GCLM, Nrf2 and HSP1a (Fig. 4a) was increased 
in HE when compared with HMA (P<0.0001). 
Increased nitrosylation (4-HNE) and high SOD2 levels 
(indicating elevated oxidative stress) were observed in 
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HE (Fig. 4b). There is a well recognised divergence 
between the transcriptome and the proteome, and while 
message for SOD2 was significantly higher in healthy 
elderly (HE) compared with the HMA group (Fig. 4a), 
the level of the translated protein SOD2 was 
significantly higher in cancer patients compared with 
healthy elderly (HE) (Fig. 4b). In addition, the 
alpha,beta-unsaturated hydroxyalkenal, 4-HNE, 
produced by cellular lipid peroxidation and indicating 
high oxidative stress, was also significantly higher in 





In contrast to some studies [20], the present study has 







































responsible for early aspects of muscle regeneration is 
higher in the skeletal muscle of the elderly and both 
cancer patient groups than in muscle from middle-aged 
controls. In particular, the markedly increased levels of 
Pax3 and particularly Pax7 in the elderly suggested a 
significant stimulation of regenerative activity. The very 
low expression of MyoG (late marker of differentiation) 
in the cancer cohort (both CWS and CWL) supports the 
concept that myogenic differentiation is impaired 
prematurely in cancer patients and that activated 
myoblasts are unable to proceed towards terminal 
differentiation and fibre remodelling [8]. Conversely, in 
the elderly muscle, myogenic capability appeared to be 
preserved. In contrast, middle-aged healthy controls 
have muscle which has not been subjected to stress or 











































change of mRNA expression  is  relative  to HMA. Statistical analysis was  carried out on deltaCT values. Q‐PCR  results  show
upregulation of pro‐apoptotic Bax (p<0.001) in HE and C (CWS and CWL) muscle compared with HMA. Expression of mRNA for
























































The need for regeneration will be increased in the 
presence of cell injury or active apoptosis. A previous 
study suggested the possibility of apoptosis in the 
muscles of humans with cancer cachexia [26]. In the 



















































and cancer groups suggesting the induction of 
apoptosis. The Nrf2-Keap1 pathway is thought to be 
central to the induction of potent cellular antioxidant 
and detoxification systems that protect against the 
induction of apoptosis [27]. In this context, down-
 
Figure 4. (a) Fold change (±SD) in mRNA expression of the oxidative defense genes SOD2, GCLM, and Nrf2 and the heat shock protein
HSP1a  in  the Quadriceps muscle of C, HE and HMA groups: HMA  (n=22), HE  (n=17), CWS  (n=18), CWL  (n=9); Fold‐change of mRNA
expression is relative to HMA participants. Statistical analysis was carried out on deltaCT values. The mRNA expression of the oxidative
defense gene SOD2 is increased in HE (p<0.0001) but decreased in CWS (p<0.001) and CWL (p<0.0001) compared with HMA. Expression
of  GCLM  is  also  increased  in  HE  (p<0.0001)  but  decreased  in  CWS  (p<0.0001)  and  CWL  (p<0.0001)  compared with  HMA.  Nrf2  is
decreased  in CWS and CWL but  increased  in HE when compared with HMA (p<0.0001) and HSP1a  is decreased  in CWS (p<0.001) but
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regulation of Nrf2, specifically in the cancer patients 
(Fig. 4a), may be important as down-regulation of Nrf2 
has been associated with increased apoptosis [19]. In 
addition, an increase in nitrosylation and oxidative 
defense proteins was detected in the muscle from cancer 
patients (Fig. 4b). These findings support the concept 
that muscle wasting in cancer and the elderly may, in 
part, be due to continuous oxidative stress and apoptosis 
[17]. 
 
Pro-inflammatory cytokines have been strongly 
implicated in the muscle wasting associated with both 
cancer and old age. In the present study, there was 
evidence of mild systemic inflammation in the cancer 
group, with approximately one third having an elevated 
circulating C-reactive protein, but not in the healthy 
elderly. Within the muscle compartment, there was 
evidence of increased expression of pro-inflammatory 
cytokines (TNF-alpha) in the healthy elderly and to a 
lesser extent in the CWS patients when compared with 
the middle-aged controls (Fig. 2a). The expression of 
IL-6 was also significantly elevated in the CWS group 
compared with the HMA group (Fig. 2a) suggesting an 
ongoing inflammatory process. Although there was no 
evidence of significant activation of NF-ĸB (pNF-ĸB) 
or an increase in the expression of NFkB protein in the 
muscle of cancer patients (Fig. 2b), this may be be due 
to the smaller sample sizes available for protein 
analyses masking a very low level of activation. 
Cytokines such as TNF-α are known to be direct 
inducers of muscle cell death, while NF-kB is known to 
block MyoD and Mef2 and inhibit muscle remodeling 
[14–16]. 
 
Cellular stress can influence the regulation of 
autophagy and apoptosis pathways [28]. Elimination 
of unwanted ROS is therefore of great importance for 
cell survival. In the present study, no evidence of 
significant transcriptional activation of cellular 
defenses (SOD2) was found in the muscle of the 
cancer patients. However, the increased levels of 
SOD2 protein and nitrosylation (indicated by 
expression of the unsaturated hydroxyalkenal 4-HNE) 
suggesting oxidative stress, were significantly higher 
in cancer patients (C) compared with healthy elderly 
(HE) (Fig. 4b). This finding directly reflects oxidative 
stress in the tissues. The lack of a transcriptomic 
response may indicate impaired defenses against 
oxidative stress which may contribute to a reduction in 
muscle regeneration. 
 
It has been suggested that autophagy is increased in 
muscle of cancer patients and contributes to increased 
protein degradation and muscle wasting [29]. In 
stressful conditions or in tissue with increased protein 
misfolding and aggregation, autophagy has an important 
role in eliminating protein aggregates. Under normal 
conditions p62 is degraded through autophagy. In the 
present study, the expression of p62 and Beclin1, which 
participates in autophagy [30], was increased in cancer 
patients compared with the healthy elderly (Fig. 3b). It 
is possible that in cancer patients mitochondrial-derived 
ROS promote skeletal muscle autophagy [19] and, in a 
murine system, a potential role for mitochondrial dys-
function and oxidative stress in autophagy-related 
pathology has been suggested [31]. Oxidative stress has 
also been reported to activate nuclear NF-κB as a result 
of p62 upregulation and TNF receptor-associated factor 
6 (TRAF6) complex formation leading to antioxidant-
defense system activation [32] and, as discussed above, 
inhibition of muscle remodelling [14–16]. 
 
Strengths and weaknesses of study 
 
One limitation of the present study was the relatively 
small sample size. An additional limitation was that the 
healthy middle-aged participants were recruited to 
provide reference data for mRNA analysis and we did 
not obtain muscle biopsies from HMA for protein 
analysis. We were unable therefore to confirm that the 
protein signatures obtained in the elderly and cancer 
groups were different from the healthy middle-aged. 
One weakness of working with human samples that are 
not longitudinal is that the samples represent a snapshot 
of the current status of the patient at a certain time point 
of the disease, which makes the correlation of the 
transcriptome with the proteome challenging, as there is 
a time delay between the change already observed in 
gene-expression and any subsequent influence on the 
proteome. Overall, our analysis can be treated as a pilot 
study for more definitive studies with larger numbers of 
participants and better defined cohorts, which will allow 
more robust comparisons at both the transcriptome and 
proteome levels. In addition, the sampling and analysis 
of different tissues (e.g. serum, urine, target tissue) 
might aid further interpretation of the data from such a 
complex human paradigm. 
 
MATERIALS AND METHODS 
 
Patients/volunteers. All subjects gave written informed 
consent prior to entry into the study.  All procedures 
were approved by the NHS Lothian local research 
Ethics Committee. The study conformed to the 
standards set by the Declaration of Helsinki. 
 
Cancer (C): 28 cancer patients were identified via the 
upper gastrointestinal cancer multi-disciplinary team 
(MDT) at the Royal Infirmary, Edinburgh, UK. Patients 
had newly diagnosed potentially resectable cancer.  
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Healthy Elderly (HE): 29 volunteers aged >75 years 
were recruited using advertisements in local newspapers 
and were defined as healthy on the basis of their 
responses to previously published health selection 
criteria [21]. None were engaged in any form of 
physical training. To exclude patients with age-related 
sarcopenia, volunteers were screened using body 
composition analysis by DEXA scanning and only those 
patients who did not fulfil the criteria for sarcopenia 
(n=21) were included. 
 
Healthy Middle Age Controls (HMA): 20 volunteers 
were recruited by using advertisements in local 
newspapers. It was confirmed that volunteers had no 
recent weight loss or any common disease associated 
with cachexia (cancer, severe COPD, congestive heart 
failure, active infectious disease). Individuals taking 
hormones or continual oral steroids were excluded.  
 
Calculation of weight loss. Pre-morbid weight was 
recalled by the cancer patients and verified where 
possible from the medical notes. Individual weight-loss 
was calculated and expressed as a percentage of pre-
morbid body weight loss. Patients were considered to be 
weight-losing (WL) if they had lost more than 5% of 
their pre-morbid weight [23]. The second group of 
cancer patients were considered as the weight-stable 
(WS) group. 
 
Measurement of C-reactive protein. C-reactive protein 
was measured in serum using an automated hospital-
based technique (Abbott TDX). 
 
Muscle biopsy. A Bergstrom needle muscle biopsy was 
obtained from the lateral mass of the quadriceps either 
under local anaesthetic (HE and HMA) or immediately 
at the start of general anaesthesia and prior to the start 
of open abdominal surgery (C). The biopsy was cleaned 
of gross blood contamination and snap frozen in liquid 
nitrogen and stored at -80°C. 
 
DEXA body composition analysis (HE and HMA). 
Dual-energy X-ray absorptiometry (DPX-L; Lunar 
Radiation Corp) was used to measure different body 
compartments (i.e. fat mass, lean mass, and bone 
mineral content). 
 
Total RNA isolation. Tissue was homogenised in Qiazol 
(Qiagen, UK) reagent using a Polytron PT1200E 
(Kinematica AG, Switzerland). Total RNA was 
extracted using miRNEasy columns (Qiagen, UK) as 
directed by the manufacturer with an on-column DNAse 
digestion step. RNA was quantified using the Nanodrop 
instrument (Labtech Intl, UK). Quality and purity of 
RNA was examined using 260/280 and 260/230 ratios. 
The Agilent bioanalyzer (Agilent, UK) was used to 
assess RNA integrity using previously published 
protocols [24]. All samples had 260/280 ratios above 
1.8, and RIN scores above 7.5. 
 
Quantitative Real-Time Polymerase Chain Reaction 
(QRT-PCR). The High Capacity RNA-to-cDNA kit 
(Applied Biosystems, UK) was used to convert 1µg of 
RNA to cDNA following the manufacturer’s directions. 
The quantitative validation of the expression of selected 
genes was performed by QRT-PCR (Applied 
Biosystems StepOne Real-Time PCR Systems) using 
custom PrimerDesign primers and applying the Sybre 
Green PCR master mix (Applied Biosystems, Foster 
City, CA, USA), following the manufacturer’s protocol. 
Reactions were run in triplicate on a StepOne Plus 
instrument (Applied Biosystems, UK). Running 
conditions were 95 °C 10 minutes followed by 40 
cycles of 95 °C 15 seconds and 60 °C 60 seconds. 
Amplification was performed for each cDNA (20ng) 
sample in triplicate. The fold change in expression of 
the target gene relative to the internal control gene 
(SDHA and CYC1) was assessed. QRT-PCR data were 
presented as the fold-change in gene expression 
normalized to average value of two common 
endogenous reference genes and relative to the control 
(HMA muscles). See Table 2 for primers for QRT-PCR.  
 
Identification of suitable reference genes. Given the 
progressive nature of the transcriptional dysregulation 
phenotype in the C, HMA and HE groups it was critical 
to determine which genes were most suitable for 
normalisation in different muscle groups. We therefore 
utilised the geNorm Housekeeping Gene Selection Kit 
(PrimerDesign) to evaluate 12 commonly used 
housekeeping genes in 3 different muscle groups. 
Reference genes tested were 18S (18S ribosomal RNA 
subunit), β-Actin (beta-actin), ATP5b (ATP synthase 
subunit 5b), B2M (beta-2 microglobulin), Top1 
(topoisomerase 1), CYC1 (cyclin D1), EiIF4a2 
(eukaryotic initiation factor 4a2), GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase), RPL13a 
(ribosomal protein L13a), SDHA (succinate 
dehydrogenase complex, subunit A), UBC (ubiquitin C) 
and YHWAZ (phospholipase A2). The geNorm output 
ranked the candidate reference gene according to their 
expression stability (M). Using this approach we 
identified 2 housekeeping genes for disease and non-
disease conditions and we determined whether the 
optimal reference genes identified for use in 
degenerating muscles were also suitable for use as a 
reference in HMA muscles.  Therefore, we identified 
SDHA and CYC1 as being the most stably expressed 
genes in healthy elderly and cancer muscles as well as 
in healthy middle age control (data not shown). These 
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two reference genes were taken for the following 
analysis. 
 
Tissue preparation for protein extraction. Skeletal 
muscle tissue was minced and ground on dry ice. 
Aliquots were weighed using an analytical balance 
(Mettler Toledo) and stored at -80°C until use.  
 
Protein extraction. Proteins were extracted from 
pulverized human skeletal muscle tissue by homo-
genizing the samples in the Precellys 24 system. 
Briefly, 300 µl of PhosphoSafe Extraction Reagent 
(Millipore) was added to minced and ground human 
skeletal muscle tissue (8mg) in Precellys 24 lysing kit 
tubes. Tissue was further homogenized using the high-
throughput homogenizer Precellys 24, for 10s.). After 
incubation on ice for 5 minutes, the lysates were spun at 





































into new tubes and spun for another 12 min at 1600xg at 
4°C. Pellets (insoluble fraction) were stored at -80°C 
until further us. Supernatants were collected and protein 
concentrations measured using the BCA Protein Assay 
Kit (Pierce) with BSA as a standard. Afterwards, 
phosphatase inhibitor cocktail (Roche) was added and 
the samples were stored at -80°C until further use. 
 
Western blots. 10 µg of human skeletal muscle protein 
extracts (see above) in reducing Laemmli SDS sample 
buffer were boiled for 5 min at 95°C and then  separated 
by SDS-PAGE on 4-20% gradient gels (Bio-Rad, 
Cressier, Switzerland), blotted to Nitrocellulose 
membranes (Bio-Rad) using the Trans-Blot Turbo 
Transfer System (Bio-Rad), blocked for 1h in blocking 
buffer (5% non-fat milk in Tris-buffered saline 0.05% 
Tween-20), incubated overnight with primary antibody, 











































Forward Primer Reverse Primer Amplification 
size (bp) 
Pax 3 TCTTACCAGCCCACATCTATTC TGGAAGGAATCGTGCTTTGG 109 
Pax 7 TGTGCCCTCAGGTTTAGTGA CCGTCGTCCTCCTTCTTGT 99 




MyoG GCCCTGATGCTAGGAAGCC CTGAATGAGGGCGTCCAGTC 110 
TNF AGGTTCTCTTCCTCTCACATAC ATCATGCTTTCAGTGCTCATG 82 
IL6 GCAGAAAACAACCTGAACCTT ACCTCAAACTCCAAAAGACCA 116 
Bax ATGGAGCTGCAGAGGATGAT CAGTTGAAGTTGCCGTCAGA 101 
P62 ACCATCCAGTATTCAAAGCATCC AAGAGGGGCACGCAGAAG 70 
SOD2 CGACCTGCCCTACGACTAC AACGCCTCCTGGTACTTCTC 132 
GCLM GGAATTATCAAATCAAAAGGCTACATT TTTTTACACATCTCAATTTTCTCTCAT 120 
NRF2 CCCAGCACATCCAGTCAGA CAGTCATCAAAGTACAAAGCATCT 91 
HSP1 GCGTGATGACTGCCCTGAT GTTGTCGGAGTAGGTGGTGAA 80 
Mef2 GCAGGAATTTGGGAACTGAGC GGAACAGCTTGTTGGTGCTG 297 
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goat anti-rabbit IgG at room temperature. Blots were 
developed using ECL (Roche, Rotkreuz, Switzerland) 
or SuperSignal West Femto substrate (Thermo 
Scientific, Wohlen, Switzerland) and exposed to Kodak 
film (Kodak, Rochester, NY, USA). Antibodies: 
p62/SQSTM1 (SIGMA, Saint Louis, MO, USA), 
Beclin-1 (clone D40C5), NF-κB p65 (clone D14E12), 
phospho-NFκB p65 (Ser536) (clone 93H1) (Cell 
Signaling Technologies, Danvers, MA, USA), 
Superoxide Dismutase-2 (MnSOD) (clone DD-17) 
(SIGMA, Saint Louis, MO, USA), goat polyclonal 4-
Hydroxynonenal (4-HNE) (Millipore, Billerica, MA, 
USA). Western blots were analyzed densitometrically 
using ImageJ software version 1.45 (NIH, Bethesda, 
MD, USA; http://rsbweb.nih.gov/ij). Band intensity of 
each sample was normalised to coomassie blue stained 
gels. 
 
Statistical analysis. For statistical analysis the SPSS 
package (IBM, UK) was utilized. As there were four 
participant groups and the bio-markers are all 
continuous we have used analysis of variance 
(ANOVA) to determine if there is evidence of 
differences across the groups.  Statistical significance of 
the Q-PCR results was assessed by the ANOVA with 
Tukey HSD correction to evaluate the differences 
between means. This analysis was carried out on the 
deltaCT values before calculation of the transcript copy 
number (fold change). The graphical representation of 
the QPCR results represents the calculated transcript 
copy number and the statistics shown in the graphs 
represents analysis based on the deltaCT values. Results 
were considered significant at P<0.05. Statistical 
analysis of the Western blot data was carried out using 
Graphpad Prism6 software package (GraphPad 
Software, Inc., La Jolla, CA, USA). Statistical 
significance of the results was assessed by the Mann 
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